Alnylam Pharmaceuticals | ALNY - 流动资产

股票价格

321.18

每天变化

-6.07 -1.85%

每月一次

-0.37%

每年

41.94%

Q2 预测

309.25

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 41.47B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	流动资产	更改		日
Acadia Pharmaceuticals	USD 1.06B		14.31M	2025-12
Agios Pharmaceuticals	USD 942.05M		91.06M	2025-12
Alnylam Pharmaceuticals	USD 4.05B		97.85M	2025-12
Amgen	USD 29.06B		1.17B	2025-12
Arrowhead Research	USD 1.17B		223.75M	2025-12
BioCryst Pharmaceuticals	USD 404.35M		48.66M	2025-12
BioMarin Pharmaceutical	USD 3.95B		98.95M	2025-12
Incyte	USD 5.02B		746.01M	2025-12
Ionis Pharmaceuticals	USD 2.99B		471.01M	2025-12
Moderna	USD 6.54B		54M	2025-12
Neurocrine Biosciences	USD 2.52B		364.3M	2025-12
Novartis	USD 30.46B		2.26B	2025-12
PTC Therapeutics	USD 2.27B		266.14M	2025-12
Regeneron Pharmaceuticals	USD 18.02B		41.2M	2025-12
Sangamo BioSciences	USD 49.89M		12.3M	2025-06
Sanofi	EUR 30.95B		8.99B	2025-12
Sarepta Therapeutics	USD 2.54B		184.37M	2025-12
Takeda	JPY 3.12T		195.82B	2025-12
Tectonic Therapeutic	USD 257.36M		15.88M	2025-12
Ultragenyx Pharmaceutical	USD 643.21M		76.58M	2025-09
Vertex Pharmaceuticals	USD 11.2B		631.4M	2025-12
Xencor	USD 599.82M		81.38M	2025-12